Stephen Willey
Stock Analyst at Stifel
(2.18)
# 2,625
Out of 4,829 analysts
131
Total ratings
34.38%
Success rate
-2.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NRIX Nurix Therapeutics | Maintains: Buy | $36 → $35 | $9.50 | +268.42% | 5 | Apr 9, 2025 | |
| NKTX Nkarta | Maintains: Buy | $15 → $14 | $1.93 | +625.39% | 3 | Mar 27, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Hold | $1.5 → $1.25 | $0.36 | +249.16% | 3 | Mar 25, 2025 | |
| VOR Vor Biopharma | Maintains: Buy | $12 → $5 | $0.15 | +3,204.69% | 5 | Mar 21, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $12 → $10 | $2.03 | +392.61% | 5 | Feb 28, 2025 | |
| GERN Geron | Maintains: Buy | $8 → $4 | $1.18 | +238.98% | 3 | Feb 27, 2025 | |
| INSM Insmed | Maintains: Buy | $97 → $96 | $65.08 | +47.51% | 6 | Feb 21, 2025 | |
| EXEL Exelixis | Maintains: Hold | $30 → $36 | $36.17 | -0.47% | 17 | Feb 12, 2025 | |
| INCY Incyte | Maintains: Hold | $75 → $77 | $58.98 | +30.55% | 5 | Feb 10, 2025 | |
| IGMS IGM Biosciences | Downgrades: Hold | $27 → $2.5 | $1.13 | +121.24% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $120 | $3.37 | +3,460.83% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $11.31 | +147.68% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $12.97 | +262.37% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.78 | +413.02% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $34 → $3 | $1.90 | +58.31% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $29 → $7 | $1.43 | +389.51% | 2 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 | $2.05 | +242.30% | 10 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.26 | +217.46% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $35.02 | +77.04% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.82 | +394.51% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.44 | +733.33% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.80 | +15,900.00% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $0.62 | +3,287.10% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $0.70 | +470.61% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $251.15 | -51.03% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $32.30 | +45.53% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $58.86 | +85.19% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $18.56 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $0.24 | +10,307.99% | 5 | Mar 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $5.95 | +286.55% | 5 | Feb 7, 2018 |
Nurix Therapeutics
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $9.50
Upside: +268.42%
Nkarta
Mar 27, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $1.93
Upside: +625.39%
Bolt Biotherapeutics
Mar 25, 2025
Maintains: Hold
Price Target: $1.5 → $1.25
Current: $0.36
Upside: +249.16%
Vor Biopharma
Mar 21, 2025
Maintains: Buy
Price Target: $12 → $5
Current: $0.15
Upside: +3,204.69%
AbCellera Biologics
Feb 28, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $2.03
Upside: +392.61%
Geron
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.18
Upside: +238.98%
Insmed
Feb 21, 2025
Maintains: Buy
Price Target: $97 → $96
Current: $65.08
Upside: +47.51%
Exelixis
Feb 12, 2025
Maintains: Hold
Price Target: $30 → $36
Current: $36.17
Upside: -0.47%
Incyte
Feb 10, 2025
Maintains: Hold
Price Target: $75 → $77
Current: $58.98
Upside: +30.55%
IGM Biosciences
Jan 10, 2025
Downgrades: Hold
Price Target: $27 → $2.5
Current: $1.13
Upside: +121.24%
Nov 14, 2024
Maintains: Buy
Price Target: $150 → $120
Current: $3.37
Upside: +3,460.83%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $11.31
Upside: +147.68%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $12.97
Upside: +262.37%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.78
Upside: +413.02%
Jul 9, 2024
Downgrades: Hold
Price Target: $34 → $3
Current: $1.90
Upside: +58.31%
May 10, 2024
Downgrades: Hold
Price Target: $29 → $7
Current: $1.43
Upside: +389.51%
Apr 12, 2024
Maintains: Hold
Price Target: $7
Current: $2.05
Upside: +242.30%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.26
Upside: +217.46%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $35.02
Upside: +77.04%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $1.82
Upside: +394.51%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.44
Upside: +733.33%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.80
Upside: +15,900.00%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $0.62
Upside: +3,287.10%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $0.70
Upside: +470.61%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $251.15
Upside: -51.03%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $32.30
Upside: +45.53%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $58.86
Upside: +85.19%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $18.56
Upside: -
Mar 7, 2018
Maintains: Buy
Price Target: $23 → $25
Current: $0.24
Upside: +10,307.99%
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $5.95
Upside: +286.55%